PACB vs STX · rev $76.2M vs P/E 101, rev $12.20B
Pacific Biosciences of California (PACB) versus Seagate Technology PLC (STX) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Seagate Technology PLC (STX) is a computer hardware company listed on NASDAQ.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
Latest reported STX revenue for 2026-07-03 was $12.20B. Net income was $3.18B. Revenue was up 34.1% from 2025-06-27 to 2026-07-03. STX currently screens at market cap $241.20B and trailing P/E 101.3.
PACB currently screens at market cap $387.1M. STX currently screens at market cap $241.20B and trailing P/E 101.3.
Not investment advice. Open the PACB and STX stock pages for the full models.
Not investment advice.